What if the future of vision restoration depends on manufacturing in microgravity? LambdaVision is using theInternational Space Station to produce artificial retinas made from hundreds of layers of light-activated protein — a process that is difficult to perfect on Earth because gravity can disrupt layer uniformity. In this episode, Dr. Nicole Wagner, LambdaVision CEO and Dr. Michael Roberts, chief scientist of the International Space Station National Lab, discuss how space-based production could improve artificial retina quality, reduce material waste, support regulatory progress, and ultimately help patients affected by macular degeneration and retinitis pigmentosa.
Podden och tillhörande omslagsbild på den här sidan tillhör
SAE Media Group. Innehållet i podden är skapat av SAE Media Group och inte av,
eller tillsammans med, Poddtoppen.